Furthermore inhibition of HIF-1α attenuated OVA-induced AHR and inflammation via VEGF suppression in bronchial epithelium [57], which is a critical effector molecule in Th2 driven allergic disease in the lung [58,59]. Here, HIF1A is linked to allergic disease.